This issue, discussed in this article, is important to mmers- I am curious as to what this group thinks about the FDA approval process.
"The Alliance began working for access to Revlimid, for multiple myeloma and myelodysplastic syndrome, in June 2002. Patients had to wait until December 2005 for FDA approval. Nearly 74,000 patients with these terminal cancers died without ever getting Revlimid.
The Alliance asked that patients get access to Velcade in June 2002. Curiously, the FDA points to this drug as proof it can work fast, but they didn't approve it until May 2003. At the time, trial results suggested that only about 25% of multiple myeloma patients should get the drug (since shown to be too low), but even with that limitation, about 2,600 patients died without ever getting Velcade."
I forgot to mention another important reason for polling this group about experimental drugs and the FDA- When the idea of the CPS was suggested, the idea of a letter forwarded to all, to sign, was also mentioned. After the patient studies are underway, I wonder if Kosada can develop some sort of e-letter for b-m.org to submit to the gov't on a subject such as this- food for thought.
http://online.wsj.com/art...
Post new comment